Yale Medicine says 5% to 10% of people see little result on GLP-1 weight loss drugs, and points to diet as one factor.
Recap by typeshit. Post by @yalemedicine on Instagram.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
Analysts say US prescriptions for both Novo's and Lilly's oral weight loss pills fell during the holiday-shortened week, suggesting a calendar effect rather than a demand drop.
Bynes explains in her own words why she began Ozempic after stepping away from her acting career. Short celebrity item with little beyond the quote.
Loading…